Ultrasound Biofeedback for Speech Sound Disorders

Speech Sound Disorders Clinical Trial

Official title:

Biofeedback and Speech Disorders

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01905449
• Other study ID #: 1303011662
• Status: Completed
• Phase: Phase 1
• Start date: May 2013
• Est. completion date: July 2016

Study information

• Verified date: April 2020
• Source: Yale University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Children with speech sound disorders will receive speech therapy using real-time images of the tongue from ultrasound. These images will be used to cue the child to change the tongue position when producing speech sounds.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 35
• Est. completion date: July 2016
• Est. primary completion date: July 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 8 Years to 50 Years

Eligibility

Inclusion Criteria:

• Participants must be native English-speaking children with no known hearing or vision deficits. Participants must be within the specified age range and have been identified as having speech production difficulties by a local speech-language therapist.

Exclusion Criteria:

• Participants will be excluded if there is a history of oral structural impairment (e.g., cleft palate), hearing or vision impairment, history of neurological impairment or injury, developmental disabilities such as Down Syndrome or Autism, or intellectual disability.

During initial testing, participants must score below a standard score of 75 on the Goldman-Fristoe Test of Articulation-2 and also score below 20% accurate on a probe list of words assessing accuracy of the /r/ sound

Related Conditions & MeSH terms

• Speech Sound Disorder
• Speech Sound Disorders

Intervention

Behavioral:
• Ultrasound visual feedback
Real-time visual displays of the tongue are used to cue participants to modify the tongue position/shape as they articulate speech sounds

Locations

Country	Name	City	State
United States	Haskins Laboratories	New Haven	Connecticut

Sponsors (1)

Lead Sponsor	Collaborator
Yale University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percent correct for target speech sound		Change in accuracy after 7 one-hour treatment sessions (3.5 weeks), and after 14 one-hour treatment sessions (7 weeks)

External Links

•   Related Info